Latest News

Should a quick bounce change what I'm willing to pay for the same guided profits?

With established business models, reliable cash flows, a strong dividend track record, and clear growth prospects, these two stocks stand out as attractive options for income-seeking investors.

Management reaffirmed growth targets and pushed AI-driven cost cuts.

Fertilizer gains offset sugar softness as debt climbed on the Caarap3 deal.

Building Solutions weakness and a $215 million tax asset define this quarter.

Power sidesteps the ERCOT queue, with service eyed for late 2027.

Fee revenue more than tripled as the marketplace model pulled margins higher.

Shareholders face fixed-share deal risk as Mt Todd's future takes shape.

Margin pressure and a CFO exit followed a sharp profit drop at the contractor.

Recurring security revenue is becoming a growing share of Allot's business.

This Halloween episode of the Hidden Gems Investing podcast tells the tales of seven financial frights.

Anthropic's highly anticipated IPO filing reveals explosive growth, surprisingly strong financials, and nearly $500 billion in future AI computing commitments.

Westwater ends the quarter debt-free, with a narrower loss and a federal loan secured.

Tariff refunds lifted margins, but management's own warnings on weak brands deserve a closer look.

Procter & Gamble's steady cash machine goes head-to-head with Starbucks' bid for a brand-led comeback, and the valuation gap may tip the scales.

Kress is the logical pick for now, as the company's longtime CFO. But other executives, both inside and outside the company, are being discussed.

Vanguard's fund offers a lower expense ratio and higher yield, but both ETFs share similar risk profiles and diversification.

LifeMD (NASDAQ:LFMD) lowered its full-year revenue and adjusted EBITDA outlook after third-quarter sales fell short of its forecast, as the virtual healthcare company cut marketing spending and took longer than expected to launch branded GLP-1 fulfillment arrangements. Revenue for the quarter ended

Fortinet (NASDAQ:FTNT) expects demand for firewall and security products to remain supported by artificial intelligence, infrastructure upgrades and operational technology risks, even as it faces tougher comparisons after an unusually strong first half of 2026, Chief Financial Officer Christiane Ohl

Profitability arrives as the company lines up a new Houston facility to expand capacity.

HireQuest (NASDAQ:HQI) reported higher third-quarter revenue as demand improved across its commercial staffing brands, but net income fell after the company recorded a non-cash write-down tied primarily to a repossessed franchise location. Revenue rose 4% to $8.8 million from $8.5 million a year ea

CapsoVision (NASDAQ:CV) reported modest third-quarter revenue growth as it prepared to introduce its artificial intelligence-assisted small bowel imaging software in the U.S. and complete a regulatory submission for its colon capsule. Revenue was $3.6 million, up 1% from the third quarter of 2025,

Journey Medical (NASDAQ:DERM) reported higher third-quarter revenue and a narrower net loss as sales of its rosacea treatment Emrosi grew, while executives said broader insurance coverage could support the product’s pricing and revenue in 2027. The company reported total revenue of $19 million for

Restructuring costs and lost service income shape the fiscal 2027 outlook.

Marine and DPF growth drove results, with the 2027 outlook now in view.